Abstract |
The ATTEMPT-CVD study was prospective randomized active-controlled trial and the main findings had been reported. According to baseline GFR and albuminuria categories, we divided the patients of the ATTEMPT-CVD study into 2 subgroups: (Group 1) the patients with at least one of eGFR of <45 ml/min per 1.73 m2 and UACR of ≥300 mg/g creatinine, defined as G3b and/or A3; (Group 2) the patients except for Group 1, defined as the other patients. In patients with G3b and/or A3, the incidence of cardiovascular events was significantly less in ARB group than in non-ARB group (11 vs 22, respectively) (HR = 0.465: 95%CI = 0.224-0.965; P = 0.040). UACR was significantly less in ARB group than in non-ARB group during follow-up period in patients with G3b and/or A3 (P = 0.0003), while eGFR, plasma BNP levels, and blood pressure were comparable between ARB and non-ARB groups. Allocation to ARB therapy was a significant independent prognostic factor for cardiovascular events in patients with G3b and/or A3 (P = 0.0268). On the other hand, in the other patients, the occurrence of cardiovascular events was comparable between ARB and non-ARB groups. In patients with advanced CKD, ARB-based therapy may confer greater benefit in prevention of cardiovascular events than non-ARB therapy.
|
Authors | Shokei Kim-Mitsuyama, Hirofumi Soejima, Osamu Yasuda, Koichi Node, Hideaki Jinnouchi, Eiichiro Yamamoto, Taiji Sekigami, Hisao Ogawa, Kunihiko Matsui |
Journal | Scientific reports
(Sci Rep)
Vol. 8
Issue 1
Pg. 3150
(02 16 2018)
ISSN: 2045-2322 [Electronic] England |
PMID | 29453374
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Angiotensin Receptor Antagonists
- Receptors, Angiotensin
|
Topics |
- Aged
- Angiotensin Receptor Antagonists
(pharmacology, therapeutic use)
- Blood Pressure
(drug effects)
- Cardiovascular System
(drug effects, physiopathology)
- Female
- Follow-Up Studies
- Glomerular Filtration Rate
(drug effects)
- Humans
- Hypertension
(complications, drug therapy, pathology, physiopathology)
- Kidney
(drug effects, physiopathology)
- Male
- Prognosis
- Receptors, Angiotensin
(metabolism)
- Renal Insufficiency, Chronic
(complications)
|